{
    "Gantt Timelines (default)": {
        "All Platform": {
            "Low": 7,
            "Most Likely": 11,
            "High": 16
        },
        "DNA": {
            "Low": 10,
            "Most Likely": 16,
            "High": 42
        },
        "RNA": {
            "Low": 10,
            "Most Likely": 16,
            "High": 42
        },
        "Protein subunit": {
            "Low": 10,
            "Most Likely": 16,
            "High": 42
        },
        "Inactivated": {
            "Low": 10,
            "Most Likely": 16,
            "High": 42
        },
        "Live-attenuated": {
            "Low": 10,
            "Most Likely": 16,
            "High": 42
        },
        "Non-replicating viral vector": {
            "Low": 10,
            "Most Likely": 16,
            "High": 42
        },
        "Replicating viral vector": {
            "Low": 10,
            "Most Likely": 16,
            "High": 42
        },
        "Other": {
            "Low": 10,
            "Most Likely": 16,
            "High": 42
        }
    },
    "Generic Gantt": {
        "0": {
            "Task ID": 1,
            "Predecessor": 0,
            "Group": "R&D activities",
            "Activities": "Pre-clinical",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "1": {
            "Task ID": 2,
            "Predecessor": 1,
            "Group": "R&D activities",
            "Activities": "Phase I",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "2": {
            "Task ID": 3,
            "Predecessor": -1,
            "Group": "R&D activities",
            "Activities": "Clinical trials manufacturing",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "3": {
            "Task ID": 4,
            "Predecessor": 2,
            "Group": "R&D activities",
            "Activities": "Phase II",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "4": {
            "Task ID": 5,
            "Predecessor": 4,
            "Group": "R&D activities",
            "Activities": "Phase III",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "5": {
            "Task ID": 6,
            "Predecessor": 5,
            "Group": "R&D activities",
            "Activities": "Vaccine regulatory approval",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "6": {
            "Task ID": 7,
            "Predecessor": 0,
            "Group": "Manufacturing activities",
            "Activities": "Start manufacturing activities at risk",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "7": {
            "Task ID": 8,
            "Predecessor": 7,
            "Group": "Manufacturing activities",
            "Activities": "Scale up and and process development",
            "Type": "Triangular",
            "Value": 0,
            "Low": 120,
            "Most Likely": 180,
            "High": 360
        },
        "8": {
            "Task ID": 9,
            "Predecessor": -1,
            "Group": "Drug substance manufacturing site ",
            "Activities": "Design and Build - to OQ complete",
            "Type": "Triangular",
            "Value": 0,
            "Low": 450,
            "Most Likely": 540,
            "High": 630
        },
        "9": {
            "Task ID": 10,
            "Predecessor": 0,
            "Group": "Drug substance manufacturing site ",
            "Activities": "Modify - to OQ complete",
            "Type": "Triangular",
            "Value": 0,
            "Low": 90,
            "Most Likely": 180,
            "High": 270
        },
        "10": {
            "Task ID": 11,
            "Predecessor": -1,
            "Group": "Drug substance manufacturing site ",
            "Activities": "Existing",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "11": {
            "Task ID": 12,
            "Predecessor": 10,
            "Group": "Drug substance manufacturing site ",
            "Activities": "DS site ready to start processing",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "12": {
            "Task ID": 13,
            "Predecessor": 8,
            "Group": "Drug substance manufacturing site ",
            "Activities": "Technology transfer",
            "Type": "Triangular",
            "Value": 0,
            "Low": 90,
            "Most Likely": 180,
            "High": 450
        },
        "13": {
            "Task ID": 14,
            "Predecessor": "12,13",
            "Group": "Drug substance manufacturing site ",
            "Activities": "DS Process Validation",
            "Type": "Triangular",
            "Value": 0,
            "Low": 60,
            "Most Likely": 90,
            "High": 120
        },
        "14": {
            "Task ID": 15,
            "Predecessor": 14,
            "Group": "Drug substance manufacturing site ",
            "Activities": "Ph III DS clinical trials manufacturing",
            "Type": "Triangular",
            "Value": 0,
            "Low": 30,
            "Most Likely": 60,
            "High": 90
        },
        "15": {
            "Task ID": 16,
            "Predecessor": "14,15",
            "Group": "Drug substance manufacturing site ",
            "Activities": "Pre-approval inspection",
            "Type": "Static",
            "Value": 7,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "16": {
            "Task ID": 17,
            "Predecessor": 16,
            "Group": "Drug substance manufacturing site ",
            "Activities": "Manufacturing License ",
            "Type": "Static",
            "Value": 30,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "17": {
            "Task ID": 18,
            "Predecessor": "6,17",
            "Group": "Drug substance manufacturing site ",
            "Activities": "Start commercial production",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "18": {
            "Task ID": 19,
            "Predecessor": -1,
            "Group": "Drug product manufacturing site",
            "Activities": "Design and Build - to OQ complete",
            "Type": "Triangular",
            "Value": 0,
            "Low": 630,
            "Most Likely": 720,
            "High": 810
        },
        "19": {
            "Task ID": 20,
            "Predecessor": -1,
            "Group": "Drug product manufacturing site",
            "Activities": "Modify - to OQ complete",
            "Type": "Triangular",
            "Value": 0,
            "Low": 120,
            "Most Likely": 240,
            "High": 360
        },
        "20": {
            "Task ID": 21,
            "Predecessor": 0,
            "Group": "Drug product manufacturing site",
            "Activities": "Existing",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "21": {
            "Task ID": 22,
            "Predecessor": -1,
            "Group": "Drug product manufacturing site",
            "Activities": "DP site ready to start processing",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "22": {
            "Task ID": 23,
            "Predecessor": "8,21",
            "Group": "Drug product manufacturing site",
            "Activities": "DP technology transfer",
            "Type": "Triangular",
            "Value": 0,
            "Low": 90,
            "Most Likely": 180,
            "High": 450
        },
        "23": {
            "Task ID": 24,
            "Predecessor": 23,
            "Group": "Drug product manufacturing site",
            "Activities": "DP Process Validation",
            "Type": "Triangular",
            "Value": 0,
            "Low": 120,
            "Most Likely": 180,
            "High": 240
        },
        "24": {
            "Task ID": 25,
            "Predecessor": "14,24",
            "Group": "Drug product manufacturing site",
            "Activities": "Ph III DP clinical trials manufacturing",
            "Type": "Triangular",
            "Value": 0,
            "Low": 30,
            "Most Likely": 60,
            "High": 90
        },
        "25": {
            "Task ID": 26,
            "Predecessor": "14,15,25",
            "Group": "Drug product manufacturing site",
            "Activities": "Pre-approval inspection",
            "Type": "Static",
            "Value": 7,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "26": {
            "Task ID": 27,
            "Predecessor": 26,
            "Group": "Drug product manufacturing site",
            "Activities": "Manufacturing License ",
            "Type": "Static",
            "Value": 30,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "27": {
            "Task ID": 28,
            "Predecessor": "6,25,27",
            "Group": "Drug product manufacturing site",
            "Activities": "Start DP production",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        },
        "28": {
            "Task ID": 29,
            "Predecessor": -1,
            "Group": "Drug product manufacturing site",
            "Activities": "Regulatory approval, manufacturing",
            "Type": "Static",
            "Value": 0,
            "Low": 0,
            "Most Likely": 0,
            "High": 0
        }
    },
    "Pri Capacity": {
        "1": {
            "India": {
                "DNA": 16.958333333333336
            },
            "USA": {
                "DNA": 30.500000000000004
            },
            "France": {
                "DNA": 0.0
            },
            "Germany": {
                "DNA": 21.0
            },
            "Spain": {
                "DNA": 10.0
            },
            "Belgium": {
                "DNA": 31.875
            },
            "Argentina": {
                "DNA": 0.0
            },
            "Indonesia": {
                "DNA": 0.0
            },
            "Japan": {
                "DNA": 1.25
            },
            "Portugal": {
                "DNA": 0.0
            },
            "Switzerland": {
                "DNA": 0.0
            },
            "UK": {
                "DNA": 0.0
            },
            "Poland": {
                "DNA": 0.0
            },
            "Italy": {
                "DNA": 0.0
            },
            "Canada": {
                "DNA": 0.0
            },
            "Bangladesh": {
                "DNA": 0.0
            },
            "Saudi Arabia": {
                "DNA": 0.0
            },
            "South Korea": {
                "DNA": 0.0
            },
            "Vietnam": {
                "DNA": 0.0
            },
            "Brazil": {
                "DNA": 0.0
            },
            "South Africa": {
                "DNA": 0.0
            },
            "China": {
                "DNA": 0.0
            },
            "Pfizer/BioNTech": {
                "DNA": 0.0
            },
            "CureVac": {
                "DNA": 0.0
            },
            "Moderna": {
                "DNA": 0.0
            }
        },
        "2": {
            "India": {
                "Protein subunit": 2580.7291666666665,
                "Non-replicating viral vector": 5161.458333333333,
                "Replicating viral vector": 5161.458333333333,
                "Other": 2828.4791666666665
            },
            "USA": {
                "Protein subunit": 1459.3749999999998,
                "Non-replicating viral vector": 2918.7499999999995,
                "Replicating viral vector": 2918.7499999999995,
                "Other": 1599.4749999999997
            },
            "France": {
                "Protein subunit": 593.75,
                "Non-replicating viral vector": 1187.5,
                "Replicating viral vector": 1187.5,
                "Other": 650.75
            },
            "Germany": {
                "Protein subunit": 359.375,
                "Non-replicating viral vector": 718.75,
                "Replicating viral vector": 718.75,
                "Other": 393.875
            },
            "Spain": {
                "Protein subunit": 281.25,
                "Non-replicating viral vector": 562.5,
                "Replicating viral vector": 562.5,
                "Other": 308.25
            },
            "Belgium": {
                "Protein subunit": 234.375,
                "Non-replicating viral vector": 468.75,
                "Replicating viral vector": 468.75,
                "Other": 256.875
            },
            "Argentina": {
                "Protein subunit": 234.375,
                "Non-replicating viral vector": 468.75,
                "Replicating viral vector": 468.75,
                "Other": 256.875
            },
            "Indonesia": {
                "Protein subunit": 39.0625,
                "Non-replicating viral vector": 78.125,
                "Replicating viral vector": 78.125,
                "Other": 42.8125
            },
            "Japan": {
                "Protein subunit": 15.625,
                "Non-replicating viral vector": 31.25,
                "Replicating viral vector": 31.25,
                "Other": 17.125
            },
            "Portugal": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Switzerland": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "UK": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Poland": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Italy": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Canada": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Bangladesh": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Saudi Arabia": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "South Korea": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Vietnam": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Brazil": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "South Africa": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "China": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Pfizer/BioNTech": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "CureVac": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            },
            "Moderna": {
                "Protein subunit": 0.0,
                "Non-replicating viral vector": 0.0,
                "Replicating viral vector": 0.0,
                "Other": 0.0
            }
        },
        "3": {
            "India": {
                "Inactivated": 4000.0000000000005,
                "Live-attenuated": 4000.0000000000005
            },
            "USA": {
                "Inactivated": 1000.0000000000001,
                "Live-attenuated": 1000.0000000000001
            },
            "France": {
                "Inactivated": 75.0,
                "Live-attenuated": 75.0
            },
            "Germany": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Spain": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Belgium": {
                "Inactivated": 250.00000000000003,
                "Live-attenuated": 250.00000000000003
            },
            "Argentina": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Indonesia": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Japan": {
                "Inactivated": 150.0,
                "Live-attenuated": 150.0
            },
            "Portugal": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Switzerland": {
                "Inactivated": 1012.5000000000001,
                "Live-attenuated": 1012.5000000000001
            },
            "UK": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Poland": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Italy": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Canada": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Bangladesh": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Saudi Arabia": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "South Korea": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Vietnam": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Brazil": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "South Africa": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "China": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Pfizer/BioNTech": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "CureVac": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            },
            "Moderna": {
                "Inactivated": 0.0,
                "Live-attenuated": 0.0
            }
        },
        "5": {
            "India": {
                "RNA": 0.0
            },
            "USA": {
                "RNA": 0.12
            },
            "France": {
                "RNA": 0.0
            },
            "Germany": {
                "RNA": 0.0
            },
            "Spain": {
                "RNA": 0.0
            },
            "Belgium": {
                "RNA": 0.12
            },
            "Argentina": {
                "RNA": 0.0
            },
            "Indonesia": {
                "RNA": 0.0
            },
            "Japan": {
                "RNA": 0.0
            },
            "Portugal": {
                "RNA": 0.13666666666666666
            },
            "Switzerland": {
                "RNA": 0.0
            },
            "UK": {
                "RNA": 0.0
            },
            "Poland": {
                "RNA": 0.0
            },
            "Italy": {
                "RNA": 0.0
            },
            "Canada": {
                "RNA": 0.0
            },
            "Bangladesh": {
                "RNA": 0.0
            },
            "Saudi Arabia": {
                "RNA": 0.0
            },
            "South Korea": {
                "RNA": 0.0
            },
            "Vietnam": {
                "RNA": 0.0
            },
            "Brazil": {
                "RNA": 0.0
            },
            "South Africa": {
                "RNA": 0.0
            },
            "China": {
                "RNA": 0.0
            },
            "Pfizer/BioNTech": {
                "RNA": 108.33333333333333
            },
            "CureVac": {
                "RNA": 91.66666666666667
            },
            "Moderna": {
                "RNA": 79.16666666666667
            }
        }
    },
    "Sec Capacity": {
        "China": 885.6033333333332,
        "USA": 1299.0,
        "India": 458.29200000000003,
        "Brazil": 75.4,
        "Thailand": 151.27333333333334,
        "France": 116.86666666666666,
        "Vietnam": 141.87,
        "Bangladesh": 34.92666666666666,
        "Australia": 50.693333333333335,
        "Russia": 63.583333333333336,
        "UK": 50.0,
        "Japan": 56.666666666666664,
        "Spain": 18.32,
        "Indonesia": 16.666666666666668,
        "South Korea": 80.10666666666665,
        "Germany": 89.33333333333333,
        "Belgium": 77.86666666666666,
        "South Africa": 57.12,
        "Argentina": 24.706666666666667,
        "Denmark": 23.333333333333332,
        "Austria": 8.333333333333334,
        "Bulgaria": 0.0,
        "Finland": 5.033333333333333,
        "Ireland": 16.666666666666668,
        "Italy": 33.333333333333336,
        "Luxemburg": 8.333333333333334,
        "Netherlands": 41.666666666666664,
        "Switzerland": 100.0,
        "Canada": 75.0,
        "Mexico": 8.333333333333334,
        "Israel": 16.666666666666668,
        "Iran": 8.333333333333334,
        "Malaysia": 25.0,
        "New Zealand": 16.666666666666668,
        "Pakistan": 8.333333333333334,
        "Saudi Arabia": 25.0,
        "Sri Lanka": 16.666666666666668,
        "Taiwan": 50.0,
        "Turkey": 16.666666666666668,
        "Senegal": 16.666666666666668
    },
    "Capacity Category": {
        "DNA": 1,
        "Inactivated": 3,
        "Live-attenuated": 3,
        "Non-replicating viral vector": 2,
        "Replicating viral vector": 2,
        "Protein subunit": 2,
        "Other": 2,
        "RNA": 5
    }
}